Antimicrobial susceptibility testing IVDs
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
12-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Biomerieux Australia Pty Ltd
Class:
Class 2
Manufactured by:
bioMerieux Inc 100 Rodolphe Street, Durham, NC, 27712 United States Of America
Therapeutic area:
CT1260 - Antimicrobial susceptibility testing IVDs
Therapeutic indications:
To be used in testing to determine the antimicrobial susceptibility profile of microorganisms such as bacteria, yeast or fungi against a range of individual antimicrobial agents.
Authorization status:
A
Authorization date:
2012-04-13
